Breast Cancer Pre-Clinical Research with Molecular Imaging. See Breast Cancer Biology Happens in Vivo and Real-Time.
Non-invasive breast cancer imaging in animal models gives preclinical researchers the power to:
Cutting-edge preclinical breast cancer research has the potential to drive treatment outcomes and be extrapolated to human studies. Featured drug treatment study with anti-angiogenic drug Mice with orthotopic xenograft tumors in the mammary fat pad were subjected to drug treatment & progression was observed. Details of the study can be obtained HERE. |
 Decreased tumor perfusion is observed following anti-angiogenic drug treatment in a mouse model. Video shows tumor contrast intensity changes during a bolus injection of Vevo MicroMarker contrast agent.  |
||||
| Molecular imaging possibilities for breast cancer
Benefit from the latest molecular imaging tools for detecting cancer-propagating molecules & proteins in animal models:
Additional resources: |
 |
Featured Literature:
- A perspective on vascular disrupting agents: preclinical tumor imaging and biological assessment. Mason PR et al. 2011 (Integr Biol (Camb). 3(4): 375-87).
- Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis and infiltrating macrophages. Zhang S et al. 2011 (Cancer Res. 71(4):1465-73).
If you have questions or require more information, please email us at info@visualsonics.com
